A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children

Exclusion criteria

• ✕-Those who received an asthma diagnosis by a clinician ≤1 year prior to recruitment must report that their respiratory symptoms were present for more than 1 year prior to recruitment.
• ✕-Individuals using oral corticosteroids daily or every other day for more than 14 days at the time of Visit 0 (Screening).
• ✕-Note: Females of child-bearing potential (post-menarche) must be abstinent or use a medically acceptable birth control method throughout the study (e.g. oral subcutaneous, mechanical, or surgical contraception).
• ✕-Note: Once the individual has been successfully treated, the interested study applicant may be reevaluated for study eligibility.